These independent CME/CE activities are supported by an educational grant from Allergan, Inc..



Chair
faculty image
William H. Catherino, MD, PhD
  • Professor and Research Head
  • Obstetrics and Gynecology
  • Uniformed Services University
  • Bethesda, Maryland

  • Date:
    Tuesday, October 31, 2017
    Time:
    7:00 AM 
    Registration/Breakfast 

     
    7:30–8:30 AM 
    Scientific Session 
    Location:
    San Antonio Marriott Rivercenter
    Salon I
    101 Bowie Street
    San Antonio, Texas

    LIVE BREAKFAST SYMPOSIUM--REGISTER NOW!

    Join an expert faculty panel of reproductive and women’s health experts to discuss critical questions about the management of uterine fibroids. Significant progress has recently been made in the management of uterine fibroids, including the development of minimally invasive procedures, fertility-sparing techniques, and pharmacologic options that hold substantial promise to improve morbidity, symptom severity, and quality of life for women with fibroids. Our distinguished faculty Dr. William H. Catherino and Dr. Ayman Al-Hendy will review best practices in patient management and relevant clinical trial data in this 60-minute satellite symposium on Tuesday, October 31 at 7:30 am.
    AGENDA
    7:30 AM
    Introduction: Impact of Uterine Fibroids
    William Catherino, MD, PhD
    7:40 AM
    Current Surgical and Minimally Invasive Treatment Options for Uterine Fibroids
    William Catherino, MD, PhD
    7:55 AM
    Current and Investigational Medical Management for Uterine Fibroids
    Ayman Al-Hendy, MD, PhD
    8:15 AM
    Q & A
    Faculty
    8:25 AM
    Concluding Remarks
    William Catherino, MD, PhD
    CME/CE Information

    Estimated time for completion of this activity:

    CME: 1.0 hour
    CNE:  1.0 hour
    CPE:  1.0 hour

    Target Audience

    This CME/CE activity is designed for obstetricians and gynecologists, reproductive endocrinologists, primary care physicians, nurse practitioners, physician assistants, nurses, pharmacists, and other clinicians involved in the management and care of patients impacted by uterine fibroids.

    Activity Goal

    The overarching goal of this initiative is to review the current treatment modalities, highlight current clinical trial data, and emerging therapy options, and discuss practical experiences regarding the approach to patient management and the impact uterine fibroids have on women.

    Learning Objective(s)

    • Discuss risk factors for uterine fibroids, including race and geographic region.
    • Summarize the efficacy and safety of current and emerging uterine fibroid therapies, including surgical and minimally invasive strategies, as well as medical management.
    • Incorporate current and emerging uterine fibroid management strategies into individualized management plans that consider patients’ desire for future pregnancy.
    • Use effective clinician-patient communication to inform patients about the impact of uterine fibroids and to discuss all available treatment options.


    CME Information: Physicians


    Statement of Accreditation

    Projects In Knowledge® is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    Credit Designation

    Projects In Knowledge® designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    CE Information: Nurses

    Projects In Knowledge® (PIK) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

    Upon completion of this course, participants will be awarded 1.00 nursing contact hour(s).

    DISCLAIMER: Accreditation refers to educational content only and does not imply ANCC, or PIK endorsement of any commercial product or service.

    CE Information: Pharmacists

    Projects In Knowledge® is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.

    This program has been planned and implemented in accordance with the ACPE Criteria for Quality and Interpretive Guidelines. This satellite symposium is worth up to 1.0 contact hour(s) (0.1 CEU). The ACPE Universal Activity Number assigned to this Application-type activity is 0052-0000-17-194-L01-P.

    Pharmacists should only claim credit commensurate with the extent of their participation in the activity.

    CME/CE Instructions


    To obtain credit for the live meeting:

    1. Sign in at the registration desk.
    2. Attend the live satellite symposium.
    3. Complete the evaluation form.
    4. Submit it to the event representative as you exit.
    5. Your certificate will be emailed to you within 4 weeks of the activity date.

    There is no fee for this activity.

    CONTRACT FOR MUTUAL RESPONSIBILITY IN CME/CE

    Projects In Knowledge has developed the contract to demonstrate our commitment to providing the highest quality professional education to clinicians, and to help clinicians set educational goals to challenge and enhance their learning experience.

    For more information on the contract, click here.

    Disclosure Information

    The Disclosure Policy of Projects In Knowledge® requires that all those who have control of content comply with the Standards for Commercial Support. Faculty, planners, PIK editorial scientific team, reviewers, and medical writers are required to disclose any personal interest or relationship they or their spouse/partner have with the supporters of this activity or any commercial interest that is discussed in their presentation. Any discussions of unlabeled/unapproved uses of drugs or devices will also be disclosed during the presentations.

    William H. Catherino, MD, PhD has received consulting fees from AbbVie Inc, Allergan plc, and Bayer.

    Ayman Al-Hendy, MD, PhD has received consulting fees from Allergan plc, AbbVie Inc, Bayer, and Myovant Sciences, Inc; and has contracted research from AbbVie Inc, Allergan plc, and NIH.

    Peer Reviewer has disclosed no relevant relationships.

    Dorothy Caputo, MA, BSN, RN (lead nurse planner) has no relevant relationships to disclose.
    Bernadette Marie Makar, MSN, NP-C, APRN-C (nurse planner) has no relevant relationships to disclose.

    Nancy J. Nordenson, MT (ASCP), MFA Medical Writer, has disclosed no relevant relationships.

    Projects In Knowledge's staff members have no relevant relationships to disclose.

    Planning Committee
    Ayman Al-Hendy, MD, PhD has received consulting fees from Allergan plc, AbbVie Inc, Bayer, and Myovant Sciences, Inc; and has contracted research from AbbVie Inc, Allergan plc, and NIH.
    William H. Catherino, MD, PhD has received consulting fees from AbbVie Inc, Allergan plc, and Bayer.

    Conflicts of interest are thoroughly vetted by the Executive Committee of Projects In Knowledge. All conflicts are resolved prior to the beginning of the activity by the Trust In Knowledge peer review process.

    The opinions expressed in this activity are those of the faculty and do not necessarily reflect those of Projects In Knowledge.

    This CME/CE activity is provided by Projects In Knowledge solely as an educational service. Specific patient care decisions are the responsibility of the clinician caring for the patient.

    These independent CME/CE activities are supported by an educational grant from Allergan, Inc..

    Projects In Knowledge is a registered trademark of Projects In Knowledge, Inc.

    2335 1